Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: J Allergy Clin Immunol. 2017 Feb 13;139(5):1575–1582.e8. doi: 10.1016/j.jaci.2016.12.952

Figure 1. Consort Diagram of Study Participants.

Figure 1

Note: NA=Non-Atopic; AD=Atopic Dermatitis; ID=Intradermal; IM=Intramuscular; Mod/Sev=Moderate/Severe.

1Methotrexate (not allowed during the study)

2The per protocol population includes participants who 1) received a full dose of vaccine, 2) provided serum samples at baseline and day 28, 3) met eligibility criteria, 4) received no prohibited medications, and 5) had no major protocol deviations.